About TearLab
TearLab is a Healthcare company based in San Diego (United States) founded in 2003, and was acquired by Accelmed in May 2020. Developer of diagnostic tests for detecting hyperosmolarity. TearLab has completed 1 acquisition, including OcuHub. Its chief executive, as recorded, is Seph Jensen. Its focus areas include Life Sciences, Ophthalmology and In-Vitro Diagnostic Tests. Its legal entity is TEARLAB CORP.
Company details
TearLab develops diagnostics for hyperosmolarty. The company offers the TearLab Osmolarity Test for revealing tear film osmolarity (a sign of dry eye disease) by testing for disease markers in tears. The test is done using its proprietary TearLab point-of-care instrument.
- Headquarters San Diego, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website tearlab.com
- Social LinkedIn X Facebook
- Acquired by Accelmed (May 2020)
- Legal Name Tearlab Corp
Funding Insights of TearLab
- Total Rounds 7
- Last Round Post-IPO — $1.75M
- First Round $1.75M
(Sep 2009)
- Investors Count 1
All 7 funding rounds of TearLab with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2015 | $1.75M | Post-IPO | – | – | – |
| Mar 2015 | $35M | Debt – Conventional | – | – | |
| Jul 2011 | $14.15M | Post-IPO | – | – | – |
| Jun 2011 | $2.32M | Post-IPO | – | – | – |
| Apr 2011 | $199,999 | Post-IPO | – | – | – |
| Jan 2010 | $1.74M | Post-IPO | – | – | – |
| Sep 2009 | $1.75M | Post-IPO | – | – | – |
2 investors in total: 2 institutional.
Investors in TearLab
TearLab has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include CRG and Accelmed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CRG is recognized as a premier healthcare investment partner. | crglp.com | Houston, United States | ||
| accelmed.com |
Investor details for TearLab
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of TearLab
12 people are tracked at TearLab (5 in leadership, 6 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Seph Jensen | CEO | Leadership |
Michael Marquez | CFO | Leadership |
Benjamin Sullivan | Chief Scientific Officer | Leadership |
Michael Berg | VP, Regulatory | Leadership |
Lynne Pratt | Director Human Resources | Leadership |
Richard Lindstrom | Directors | Board & advisors |
Dylan Harmon | Director | Board & advisors |
Uri Geiger | Director | Board & advisors |
Dolev Rafaeli | Director | Board & advisors |
Jim Mazzo | Director | Board & advisors |
Barak Azmon | Director | Board & advisors |
Nadeen Dagel | Quality Systems Manager | Team |
Complete people profiles for TearLab
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TearLab
TearLab has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include OcuHub.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cloud-based health information platform for payers and doctors | ocuhub.com | Marietta, United States | 2014 | Mar 2014 | •••• |
Complete acquisition details for TearLab
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of TearLab
6 dated milestones of TearLab across 17 years, from founding to its latest funding, stage changes and deals.
- Founded TearLab is founded.
- Funding First funding round of $1.7M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires OcuHub.
- Funding Latest funding round, Post-IPO, of $1.8M.
- Exit Acquired by Accelmed.
Web traffic of TearLab
Websites that share an audience with TearLab (tearlab.com).
Websites whose visitors overlap most with TearLab. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
optometricmanagement.com | optometricmanagement.com | 100% | #1,825,484 | – | |
| bausch.com | 99% | 175.4K | #271,734 | View details | |
| rpsdetectors.com | 77% | View details | |||
marco.com | marco.com | 74% | #2,440,158 | – | |
optometrytimes.modernmedicine.com | optometrytimes.modernmedicine.com | 73% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for TearLab
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Ophthalmology
3 companies that operate in the same segment as TearLab (Ophthalmology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tearlab
Complete news archive for TearLab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TearLab
TearLab was founded in 2003 and raised its 1st funding round 6 years after it was founded.
TearLab is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Seph Jensen is the CEO of TearLab, as recorded in our data.
Annual revenue of TearLab is $22.66M as on Dec 31, 2019.
TearLab develops diagnostics for hyperosmolarty. The company offers the TearLab Osmolarity Test for revealing tear film osmolarity (a sign of dry eye disease) by testing for disease markers in tears. The test is done using its proprietary TearLab point-of-care instrument.
TearLab has made 1 acquisition, including OcuHub.
TearLab has 2 investors. Key investors include CRG, and Accelmed.
TearLab operates through Tearlab Corp.
Yes. TearLab was acquired by Accelmed in May 2020.